Biltstraat 106

3572 BJ, Utrecht, the Netherlands

info@virology-education.com

  • White Twitter Icon
  • White LinkedIn Icon
  • White Facebook Icon

Tel: +31 (0)30 230 7140

© 2020 by Virology Education

Enduring Materials

Session 1: Current controversies for cART use in women of child bearing potential and in pregnancy

Clinical case: Researcher perspective

Tendani Gaolathe, MD

Botswana Harvard AIDS Institute Partnership, Botswana

button_slides.png
button_video.png

Session 1: Current controversies for cART use in women of child bearing potential and in pregnancy

Clinical case: Community perspective

Lucy Wanjiku Njenga

Positive Young Women Voices, Kenya

button_video.png

Session 1: Current controversies for cART use in women of child bearing potential and in pregnancy

Clinical case: Policy implications

Meg Doherty, MD, PhD

WHO, UK

button_slides.png
button_video.png

Session 1: Current controversies for cART use in women of child bearing potential and in pregnancy

ABSTRACT

INSTI exposure and neural tube defects – data from antiretroviral pregnancy registry

Jessica Albano, PhD, MPH

Syneos Health, USA

button_slides.png

Session 1: Current controversies for cART use in women of child bearing potential and in pregnancy

ABSTRACT

Congenital anomalies in infants of Canadian women exposed to antiretrovirals including dolutegravir

Deborah Money, MD

UBC, Canada

button_slides.png

Session 1: Current controversies for cART use in women of child bearing potential and in pregnancy

ABSTRACT

Evaluation of neural tube defects after exposure to Raltegravir during pregnancy

Hala Shamsuddin, MD

Merck, USA

button_slides.png

Session 2: New drug delivery systems, are they right for women?

Invited lecture, focus on cabotegravir

Annemiek de Ruiter, MBBS FRCP, MD

ViiV Healthcare, UK

Session 2: New drug delivery systems, are they right for women?

Emerging drug delivery systems for treatment and prevention of HIV

Kimberly Scarsi, PharmD, MS

University of Nebraska, USA

button_slides.png
button_video.png

Session 2: New drug delivery systems, are they right for women?

ABSTRACT

Clinical development strategy to inform dosing of antiretroviral drugs in women: dolutegravir as a case study

Kimberly Adkison, PhD

Viiv Healthcare, USA

button_slides.png

Session 2: New drug delivery systems, are they right for women?

ABSTRACT

HIV risk and characteristics of women seeking PrEP in a US demonstration project

Jill Blumenthal, MD

University of California, San Diago, USA

button_slides.png

Session 3: Unique challenges of growing up with HIV

Not available due to confidentiality

Session 3: Unique challenges of growing up with HIV

ABSTRACT

High PrEP uptake among HIV-exposed women with pregnancy plans in South Africa

Lynn Matthews, MD

University of Alabama at Birmingham, USA

button_slides.png

Session 3: Unique challenges of growing up with HIV

ABSTRACT

Innovative intervention for pregnant and breastfeeding adolescent mothers to enhance viral suppression in Homa Bay County, Kenya

Elizabeth Okoth (presented by N. Rakhmanina), MPH

Elizabeth Glaser Pediatric AIDS Foundation, Kenya

button_slides.png

Session 4: Healthy aging with HIV for women

Bone Health among women aging with HIV

Michael Yin, MD

New York State Psychiatric Institute & Columbia University, USA

button_slides.png
button_video.png

Session 4: Healthy aging with HIV for women

Cardiac Muscle Health Among Women Aging with HIV

Markella Zanni, MD

MGH/Harvard Medical School, USA

button_slides.png
button_video.png

Session 4: Healthy aging with HIV for women

Important Drug- Drug interactions in Women aging with HIV

Marta Boffito, MD, PhD

SSAT & Imperial College, Chelsea and Westminster Hospital, UK

button_slides.png
button_video.png

Session 5: Research in women and HIV - 1

ABSTRACT

Non-Vaccine Oncogenic HPV Persistence Among HPV-Vaccinated Women Living with HIV

Elisabeth McClymont

University of British Columbia, Canada

button_slides.png

Session 5: Research in women and HIV - 1

ABSTRACT

Dolutegravir pharmacokinetics during pregnancy and postpartum

Angela Colbers, PhD

Radboud University Medical Center, The Netherlands

button_slides.png

Session 5: Research in women and HIV - 1

ABSTRACT

Intimate Partner Violence, Depression, and Mortality among a Cohort of Women living with HIV Marginalized by Socio-structural Inequities in Vancouver, Canada

Kalysha Closson

University Of British Columbia, Canada

button_slides.png

Session 5: Research in women and HIV - 1

ABSTRACT

Vaginal microbiome and associations with tenofovir diphosphate and lamivudine triphosphate in cervical tissues of Ugandan women

Melanie Nicol, PharmD, PhD

University of Minnesota, USA

button_slides.png

Session 6: HIV cure research - considerations for women

HIV Cure: Where have we been, where are we going?

Daniel Kuritzkes, MD

Harvard Medical School, USA

button_slides.png
button_video.png

Session 6: HIV cure research - considerations for women

Invited lecture: Focus on women

Jintanat Ananworanich, MD, PhD

US Military HIV Research Program, USA

button_slides.png
button_video.png

Session 6: HIV cure research - considerations for women

ABSTRACT

Women’s involvement in clinical research: Women included in Dolutegravir clinical trials versus collaborative studies

Romina Quercia, MD, PhD, MPH

ViiV Healthcare, UK

button_slides.png